-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-906 in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMS-906 in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OMS-906 in Paroxysmal Nocturnal Hemoglobinuria Drug Details: OMS-906 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-906 in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMS-906 in Kidney Disease (Nephropathy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OMS-906 in Kidney Disease (Nephropathy) Drug Details: OMS-906 is under development...
-
Thematic Analysis
NewIndia Impact on Medical Devices – Thematic Intelligence
India's medical devices sector has been steadily growing in strength and significance in recent years. With a diverse and rapidly expanding healthcare market, India has become an increasingly attractive destination for medical device manufacturers and investors alike. The sector benefits from India's large patient population, rising healthcare expenditure, and growing demand for advanced medical technologies. Additionally, favorable government policies and initiatives aimed at promoting domestic manufacturing and attracting foreign investment have further bolstered the sector's growth. India's medical devices industry...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-527 in Smoking Cessation Drug Details: OMS-527 is under development for the treatment of movement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Substance (Drug) Abuse
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-527 in Substance (Drug) Abuse Drug Details: OMS-527 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PD-1 Silent PSMA Or PSCA Targeted CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PD-1 Silent PSMA Or PSCA Targeted CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PD-1 Silent PSMA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986218 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986218 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986218 in Non-Small Cell Lung Cancer Drug Details: BMS-986218...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-101 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Diffuse Large B-Cell Lymphoma Drug Details: AT-101...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dexamethasone Sodium Phosphate in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OMS-906 in Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OMS-906 in Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.OMS-906 in Arthritis Drug Details:OMS-906 is under development for the treatment of paroxysmal nocturnal...